-
Start Preamble
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Notice of meeting.
SUMMARY:
The Food and Drug Administration (FDA) is announcing the following meeting: Office of Women's Health Update on Strategic Priorities and Initiatives. FDA staff will provide updates on strategic priorities, educational outreach, and research initiatives of interest to national organizations for nursing professionals and students.
DATES:
The meeting will be held on November 18, 2015, 1 p.m. to 3 p.m.
ADDRESSES:
The meeting will be held at the American Nurses Association, 8515 Georgia Ave., Suite 400, Silver Spring, MD 20910-3492.
Start Further InfoFOR FURTHER INFORMATION CONTACT:
Deborah Kallgren, Office of Women's Health, Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993-0002, 301-796-9440, FAX: 301-847-8604, deborah.kallgren@fda.hhs.gov.
End Further Info End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
There is no fee, but pre-registration is required. Send registration information (including name, title, organization name, address, telephone, and fax number) to Deborah Kallgren. Seating is limited to 35 participants (1 person per organization).
If you need special accommodations due to a disability, please contact Deborah Kallgren (see FOR FURTHER INFORMATION CONTACT) at least 7 days in advance.
Start SignatureDated: October 13, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015-26433 Filed 10-16-15; 8:45 am]
BILLING CODE 4164-01-P
Document Information
- Published:
- 10/19/2015
- Department:
- Food and Drug Administration
- Entry Type:
- Notice
- Action:
- Notice of meeting.
- Document Number:
- 2015-26433
- Dates:
- The meeting will be held on November 18, 2015, 1 p.m. to 3 p.m.
- Pages:
- 63234-63234 (1 pages)
- Docket Numbers:
- Docket No. FDA-2015-N-0001
- PDF File:
- 2015-26433.pdf
- Supporting Documents:
- » Attachment 3 Neurovascular Quality Initiative List of Devices re: Comment from M2S, Inc.
- » Attachment 2 Neurovascular Quality initiative 2015 Procedure Inclusion/Exclusion Criteria re: Comment from M2S, Inc.
- » Transcript of the March 30-31, 2015 Gastroenterology Regulatory Endpoints and the Advancement of Therapeutics (GREAT) III Workshop on Inflammatory Bowel Disease, Day 2
- » Transcript of the March 30-31, 2015 Gastroenterology Regulatory Endpoints and the Advancement of Therapeutics (GREAT) III Workshop on Inflammatory Bowel Disease, Day 1